Cannabis Law Report

AUGUST 3, 2021

CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Data Bridge Market Research believes that psychedelics will grow at a 13.3%

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 30, 2021

According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. of patients with social anxiety disorder.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

MARCH 25, 2019

Permits the distribution of medicinal marihuana only to hospitals and pharmacies registered to dispense Schedule II controlled substances for the purposes of treating glaucoma or the nausea of cancer patients or research approved under the Federal Food, Drug, and Cosmetic Act.”. [ii] 2030 , 2068, 2070; Pub. 10, 1978 , 92 Stat.

Banking 45

Banking Law Marijuana State Laws 45